Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › MDM2 inhibitor and a platinum compound for cancer treatment

MDM2 inhibitor and a platinum compound for cancer treatment

US Patent 11850239 · Granted Dec 26, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combination product of a Bcl-2/Bcl-xL inhibitor and a chemotherapeutic agent and2025
Combination product of a Bcl-2/Bcl-xL inhibitor and a chemotherapeutic agent and2025
N-(phenylsulfonyl)benzamides and related compounds as Bcl-2 inhibitors2025
N-(phenylsulfonyl)benzamides and related compounds as Bcl-2 inhibitors2025
Storage shed2025
Storage box2025
Method and compositions for predicting anti-cancer efficacy of compounds targeti2025
Method and compositions for predicting anti-cancer efficacy of compounds targeti2025
Combination of immunotherapies with MDM2 inhibitors2025
Combination of immunotherapies with MDM2 inhibitors2025
Storage shed2025
Pharmaceutical combination and use thereof2025